Usefulness of acetylsalicylic acid in the prevention of preeclampsia

Authors

  • Marleni Hernández Parets Universidad de Ciencias Médicas de Villa Clara
  • Melba Zayas González Universidad de Ciencias Médicas de Villa Clara
  • Aimee Escobar Blanco Universidad de Ciencias Médicas de Villa Clara

Keywords:

aspirin, pre-eclampsia, disease prevention

Abstract

Introduction: aspirin is one of the most common drugs used in therapeutics. It is included in the list of essential medications of the World Health Organization, has been used by humans for 2400 years and was synthesized for the first time in 1853. Objective: to discuss its effects in the prevention of preeclampsia. Method: theoretical methods were used, as well as the analysis and interpretation of the available information on the use of aspirin in the prevention of preeclampsia. Development: acetylsalicylic acid is the nonsteroidal anti-inflammatory par excellence. It is commonly used in the treatment of pain, inflammation or fever. Preeclampsia is a multi-organ disease characterized by the appearance of hypertension and proteinuria in the second half of the pregnancy; its prevalence is approximately 7.5% of pregnancies and it is an important cause of perinatal and maternal morbility and mortality. There are different interventions for the prevention of preeclampsia such as low-salt diet, diuretics, supplementation with calcium, antioxidants, aspirin or heparin. It has been proven that low doses of aspirin reduce the risk of developing this syndrome, in spite of the controversy about its effectiveness and the best moment of administration in pregnant women. Conclusions: the usefulness of aspirin in the prevention of preeclampsia in high-risk women is shown by several actions related with the factors involved in the pathogenesis of the disease, and its efficacy has been demonstrated by numerous clinical trials conducted around the world.

Downloads

Download data is not yet available.

Author Biographies

Marleni Hernández Parets, Universidad de Ciencias Médicas de Villa Clara

Especialista de II Grado en Farmacología. Máster en Medicina Bioenergética y Natural. Profesora Asistente de la Universidad de Ciencias Médicas de Villa Clara.

Melba Zayas González, Universidad de Ciencias Médicas de Villa Clara

Especialista de I Grado en Farmacología. Máster en Longevidad Satisfactoria. Profesora Auxiliar de la Universidad de Ciencias Médicas de Villa Clara.

Aimee Escobar Blanco, Universidad de Ciencias Médicas de Villa Clara

Especialista de I Grado en Medicina General Integral. Máster en Urgencias Médicas. Profesora Asistente de la Universidad de Ciencias Médicas de Villa Clara.

References

1. Grosser T, Smyth EM, Fitzgerald GA. Antiinflamatorios, antipiréticos y analgésicos; farmacoterapia de la gota. En: Brunton LM, Chabner BA, Knollmann BC. Goodman & Gilman. Las bases farmacológicas de la terapéutica. 12na ed. México: McGraw–Hill Interamericana Editores; 2012. p. 959.

2. Flores Beledo J, Armijo Simón JA, Mediavilla Martínez A. Farmacología humana. Fármacos analgésicos antipiréticos y antiinflamatorios no esteroideos. Antiartríticos. 6ta ed. España: Elsevier Masson; 2014.

3. Souza EV, Torloni MR, Atallah AN, Dos Santos GMS, Kula L, Sass N. Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial. Braz J Med Biol Res [Internet]. 2014 May [citado 7 Abr 2017];47(5):419-425. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075311/

4. Smyth EM, Grosser T, Fitzgerald GA. Autacoides derivados de los lipidos: eicosanoides y factor activador de las plaquetas. En: Brunton LM, Chabner BA, Knollmann BC. Goodman & Gilman. Las bases farmacológicas de la terapéutica. 12th ed. México: McGraw–Hill Interamericana Editores; 2012. p. 939.

5. World Health Organization. WHO recommendations for prevention, treatment of pre-eclampsia, and eclampsia. World Health Organization; 2014. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/44703/9789241548335_eng.pdf;jsessionid=7487F6111E09CB3D02E97C3B95AF9318?sequence=1

6. Rodríguez Domínguez P, Báez Villa A, Domínguez Rodríguez JE. Uso de la aspirina en la prevención de la preeclampsia. Rev Cubana Med Gen Integr [Internet]. 2001 Oct [citado 7 Abr 2017];17(5):441-445. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252001000500006&lng=es

7. Herrera Murgueitio JA. Reducción de la mortalidad materna por preeclampsia mediante la aplicación de un modelo biopsicosocial en Colombia [tesis]. Madrid: Universidad de Alcalá; 2013. Disponible en: https://ebuah.uah.es/dspace/bitstream/handle/10017/20365/TESIS_HERRERA_MURGUEITIO.pdf?sequence=1&isAllowed=y

8. Henderson JT, Whitlock EP, O'Conner E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for the prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. preventive services task force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014. Report No.: 14-05207-EF-1. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK196392/

9. August P, Sibai BM. Preeclampsia: Clinical features and diagnosis. [Internet]. 2014 [actualizado 27 Jun 2018; citado 7 Abr 2017]. Disponible en: https://www.uptodate.com/contents/preeclampsia-clinical-features-and-diagnosis

10. Cunill López ME, Sanabria Negrín JG, González Pérez A. Dosis bajas de aspirina en la preeclampsia leve. Rev Cubana Obstet Ginecol [Internet]. 1997 Jun [citado 7 Abr 2017];23(1):43-48. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X1997000100008&lng=es

11. Roberge S, Villa P, Nicolaides K, Gigupere Y, Vainio M, Bakthi A,et al. Early administration of low-dose aspirin for the prevention of pretermino and term preeclampsia: A systematic review and meta-analysis. Fetal Diagn Ther [Internet]. 2012 [citado 7 Abr 2017];31(3):141-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22441437

12. Björk Wilhelms D, Mirrasekhian E, Zajdel J, Kumar A, Engblom D. Cyclooxygenase isoform exchange blocks brain-mediated inflammatory symptoms. Plos One [Internet]. 2016 [citado 18 Nov 2016];11(11):[aprox. 8p.] Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115700/

13. Souza EV, Torloni MR, Atallah AN, dos Santos GM, Kulay L, Sass N. Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial. Braz J Med Biol Res [Internet]. 2014 [citado 6 feb 2015];47(5):419-425. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075311/

14. Huertas E. Aspectos preventivos de la preeclampsia. Rev Per Ginecol Obstet [Internet]. 2006 [citado 7 Abr 2017];52(4):226-228. Disponible en: http://sisbib.unmsm.edu.pe/BVRevistas/ginecologia/vol52_n4/pdf/A06V52N4.pdf

15. Karumanchi S, Lim KH, August P. Pathogenesis of preeclampsia [Internet]. 2014 [actualizado 27 Jun 2018; citado 7 Abr 2017]. Disponible en: https://www.uptodate.com/contents/preeclampsia-pathogenesis

16. Hou L, Zhu Y, Ma X, Li J, Zhang W. Serum protein microarray analysis of patients with preeclampsia. Mol Med Rep [Internet]. 2012 Jul [citado 7 Abr 2017];6(1):83-7. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22505006

17. Katzung BG. Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics, & Drugs Used in Gout. Basic & Clinical Pharmacology. 12 th ed. New York: McGraw-Hill; 2012.

18. Velásquez Berrio M, Gil-Villa AM, Cadavid Jaramillo AP. Lipoxinas inducidas por la aspirina: una alternativa para modular los procesos proinflamatorios en la preeclampsia. Rev Cubana Obstet Ginecol [Internet]. 2013 Jul-Sep [citado 10 feb 2015];39(3):[aprox. 13p.]. Disponible en: http://scielo.sld.cu/pdf/gin/v39n3/gin09313.pdf

19. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcou S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet Gynecol [Internet]. 2010 Aug [citado 10 Feb 2015];116(2 pt 1):402-14. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/20664402

20. Roberge S, Sibai B, Mc Caw-Binns A, Bujold E. Low-dose aspirin in early gestation for prevention of preeclampsia and small-for-gestational-age neonates: meta-analysis of large randomized trials. Am J Perinatol [Internet]. 2016 Jul [citado 15 Sep 2016];33(8):781-5. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26906184

21. Meher S, Alfirevic Z. Aspirin for pre-eclampsia: beware of subgroup meta-analysis. Ultrasound Obstet Gynecol [Internet]. 2013 [citado 6 feb 2015];41:[aprox.7p.]. Disponible en: https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1002/uog.12470

22. Schramm AM, Clowse ME. Aspirin for Prevention of Preeclampsia in Lupus Pregnancy. Autoimmu Dis [Internet]. 2014 [citado 6 feb 2015];2014:[aprox. 8 p.]. Disponible en: https://www.hindawi.com/journals/ad/2014/920467/

23. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol [Internet]. 1999 Feb [citado 10 Feb 2015];180 (2 Pt 1):499-506. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/9988826

24. Cairo González VM, Suárez González JA, Escobar Blanco A, López Guerra RL, Marín Tápanes Y, Gutiérrez Machado M. Resultados del uso del ácido acetilsalicílico y los suplementos de calcio en la prevención de la preeclampsia. Rev Cubana Obstet Ginecol [Internet]. 2017 Jul-Sep [citado 10 Feb 2015];43(3):[aprox. 16p.]. Disponible en: http://scielo.sld.cu/pdf/gin/v43n3/gin08317.pdf

25. Lorenzo P, Moreno A, Leza JC. Velázquez. Farmacología básica y clínica. 17 th ed. España: Editorial Médica Panamericana; 2005.

26. Hernández Pacheco JA, Espino y Sosa S, Estrada Altamirano A, Nares Torices MA, Ortega Casitillo VM, Mendoza Calderón SA, et al. Instrumentos de la Guía de Práctica Clínica. Diagnóstico y Tratamiento de la preeclampsia y eclampsia en el embarazo, parto y puerperio. Perinatol Reprod Hum [Internet]. 2013 Oct-Dic [citado 20 feb 2015];27(4):[aprox. 19 p.]. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0187-53372013000400009

27. Alcalá Lorente M, Navarro Rubio G. Prevención de la preeclampsia con aspirina. Prog Obstet Ginecol [Internet]. 2015 Oct [citado 25 Abr 2017];58(8). Disponible en: http://www.elsevier.es/es-revista-progresos-obstetricia-ginecologia-151-avance-prevencion-preeclampsia-con-aspirina-S0304501315001624

Downloads

Published

2018-10-29

How to Cite

1.
Hernández Parets M, Zayas González M, Escobar Blanco A. Usefulness of acetylsalicylic acid in the prevention of preeclampsia. Acta Méd Centro [Internet]. 2018 Oct. 29 [cited 2025 Jul. 1];13(1):110-8. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/947

Issue

Vol. 13 No. 1 (2019): January-March

Section

Review Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).